Liu Shi Xin

Nueva
40 años de experiencia
Ubicación: China, Xiamen
Clínica:Hospital Xiamen Humanity
El profesor Shixin Liu, MD, PhD, es el líder de la disciplina del Centro de Oncología. Fue presidente del Hospital Oncológico Provincial de Jilin y director del Instituto de Investigación en Prevención y Tratamiento del Cáncer. Es profesor de nivel II y tutor de doctorado. Ha recibido la Asignación Especial del Gobierno del Consejo de Estado, el 4.º premio Médico Nacional Famoso (Contribución Sobresaliente) y la distinción Modelo de Ética Médica.

Se especializa en el diagnóstico y tratamiento integrales de tumores malignos. Su enfoque es la radioterapia de precisión para cánceres torácicos y abdominales. Domina IMRT, VMAT y SBRT para cáncer de pulmón, esófago, mama y recto.

Sus cargos de liderazgo incluyen la vicepresidencia de Oncología Radioterápica de la CMA, de Radioterapia de la CACA y de Terapia de Partículas de la CACA. Integra el Comité Permanente de la CSCO y es vicepresidente del Comité de Expertos en Oncología Radioterápica de la CSCO. Es vicepresidente de Oncología Radioterápica de la CPAM y miembro del Comité Permanente de la CSMEA. Preside la sección de Oncología Radioterápica de la Asociación Médica de Jilin. Forma parte de los consejos editoriales del Chinese Journal of Radiation Oncology y del Practical Journal of Cancer.
Mostrar más

Nueva

Cita con el médico

Precio a consultar

Bookimed Insights: Principales especialistas en Adenocarcinoma en China (2026)

Bookimed ha coordinado 1 solicitudes para el tratamiento de Adenocarcinoma en China, colaborando con 1 especialistas de primer nivel. Los médicos en esta tabla se seleccionan por sus credenciales internacionales, experiencia clínica y resultados de pacientes. La clasificación de 2026 se elabora con datos verificados de casos reales y programas actuales de nuestras clínicas asociadas.

Clasificación	Médico	experiencia	Buena opción para	Qué los distingue	Ubicación de la clínica	Consulta

FAQ

Estas preguntas frecuentes provienen de pacientes reales que buscan atención médica a través de Bookimed. Las respuestas son proporcionadas por coordinadores médicos experimentados y representantes autorizados de las clínicas.

What innovative treatments are available for adenocarcinoma in China that might not be available elsewhere?

China offers unique adenocarcinoma treatments including CAR-T therapy for solid tumors and early-access oncolytic viruses. Facilities like Fuda Cancer Hospital specialize in minimally invasive cryoimmunotherapy for advanced stages. These protocols often receive regulatory approval years before Western markets. Patients access specific therapies targeting the Claudin18.2 protein.

Solid tumor CAR-T: Targets specific proteins in gastric and pancreatic adenocarcinomas.
Cryoimmunotherapy: Combines tumor freezing with immunotherapy to trigger systemic immune responses.
Oncolytic viruses: Genetically modified viruses specifically infect and destroy glandular cancer cells.
Advanced radiosurgery: The CyberKnife M6 system provides non-invasive treatment for precise tumor targeting.

Bookimed Expert Insight: China is a hub for late-stage cancer care because facilities like Fuda Cancer Hospital combine over 10 types of minimally invasive therapies. Our data shows hospitals here often manage 1,000,000 patients annually. This high volume allows surgeons to refine techniques like NanoKnife and microwave hyperthermia faster than in lower-volume regions. This practical experience is vital for complex adenocarcinoma cases.

Patient Consensus: Patients note that seeking treatment in China often provides earlier access to experimental therapies through active clinical trials. Many emphasize the importance of consulting both local and international oncologists to verify efficacy data before starting newer immunotherapy combinations.

Can Traditional Chinese Medicine (TCM) be integrated with standard adenocarcinoma treatments?

Traditional Chinese Medicine (TCM) is frequently integrated with standard adenocarcinoma treatments in China to enhance outcomes. This integrated approach combines Western tumor-targeting therapies with TCM's holistic focus. It helps mitigate side effects like nausea or fatigue from chemotherapy while supporting the patient’s immune system through recovery.

Targeted synergy: TCM herbs may act as sensitizers for chemotherapy or radiotherapy efficacy.
Symptom management: Acupuncture and herbal formulas help reduce postoperative pain and appetite loss.
Integrated protocols: Standard treatments like CyberKnife M6 are often paired with supportive herbal medicine.
Advanced diagnostics: Clinics utilize PET/CT and scintigraphy alongside traditional pulse and tongue analysis.

Bookimed Expert Insight: Patient data from Jinshazhou Hospital of Guangzhou University of Chinese Medicine reveals a significant trend where advanced technologies like CyberKnife M6 are physically housed within TCM-affiliated institutions. This proximity suggests that integration isn't just a philosophy but a structural reality in China. For around $7,700, patients can access high-precision radiosurgery packages that already include the necessary medical consultations for a combined treatment plan.

Patient Consensus: Patients emphasize that TCM should be a side-by-side support rather than a replacement for surgery or chemotherapy. Many note it is essential to disclose herbal use to oncologists to avoid potential liver metabolism interactions.

Which cities and hospitals are considered best for cancer care in China?

Beijing, Shanghai, and Guangzhou are the primary hubs for cancer care in China. These cities host national centers like the Cancer Hospital of the Chinese Academy of Medical Sciences. Facilities often feature Joint Commission International (JCI) accreditation and specialize in advanced therapies like CyberKnife and NanoKnife.

Beijing leadership: Home to the National Cancer Center with the highest reported survival rates.
Guangzhou expertise: Jinshazhou Hospital offers advanced CyberKnife M6 stereotactic radiosurgery for targeted treatment.
Shanghai specialization: Fudan University Shanghai Cancer Center excels in adenocarcinoma and genomic profiling.
Patient capacity: Xiamen Humanity Hospital manages over 1,000,000 patients annually with 1,000 beds.

Bookimed Expert Insight: Guangzhou holds a unique position for international patients due to a concentration of minimally invasive technologies. Fuda Cancer Hospital has treated over 30,000 international patients using specialized cryosurgery and NanoKnife protocols. While Beijing centers focus on national research, Guangzhou clinics often provide more accessible high-tech packages. For instance, CyberKnife M6 treatments in the region cost around $7,700 and include transfers and hotel stays.

Patient Consensus: Patients emphasize bringing original pathology slides to avoid diagnostic delays. They note that JCI-accredited facilities provide better English support and more organized care transitions for international visitors.

What is required for payment or insurance coverage as a foreign patient?

Foreign patients in China usually pay 100% upfront for adenocarcinoma treatments. Most hospitals require proof of funds for admission. Large payments typically move via wire transfer, Alipay, or WeChat Pay. International health insurance often requires pre-authorization 2 to 4 weeks before arrival.

Payment timing: Full estimated costs are typically required before treatment begins.
Local currency: Hospitals prioritize Renminbi (RMB) for all major inpatient transactions.
Insurance approval: Most global insurers must approve medical reports before travel.
Billing documents: Always request detailed, itemized invoices in English for reimbursement.

Bookimed Expert Insight: CyberKnife M6 packages in Guangzhou, costing approximately 56,000 CNY, often exclude hospital stays. Our data shows specialized centers like Fuda Cancer Hospital serve 30,000+ international patients. These JCI-accredited facilities often require separate budgeting for hotel accommodation. Always confirm which services are bundled to avoid payment delays.

Patient Consensus: Patients note that foreign credit cards often fail for large medical bills. They recommend having high-limit bank transfers or local mobile payment apps ready. Many found that international insurers might label certain advanced therapies as experimental, making upfront cash essential.

How are language barriers and logistics handled for international patients?

Chinese hospitals manage international patients through dedicated international departments providing on-site medical interpreters and JCI-accredited coordination services. Logistics often include visa assistance, airport transfers, and digital communication tools like WeChat groups. Integrated packages typically bundle surgical consultations, medication, and local transportation for seamless care.

Language support: On-site interpreters facilitate communication between patients, physicians, and nursing staff.
Logistics management: International departments oversee airport pickups, clinical transfers, and medical visa documentation.
Coordinated packages: Specialized bundles include hospital stays, hotel proximity, and pre-treatment video consultations.
Digital integration: Clinics use real-time messaging apps to provide progress updates and administrative help.

Bookimed Expert Insight: While top-tier facilities like Fuda Cancer Hospital serve thousands of international patients, logistics vary by city. Packages at Jinshazhou Hospital in Guangzhou often include clinic transfers. However, Xiamen Humanity Hospital serves nearly 1,000,000 patients annually. Choosing high-volume centers ensures streamlined administrative protocols for foreign medical records and faster visa processing.

Patient Consensus: Patients note that doctors often speak fluent English, but nursing staff may not. They recommend setting up digital payment apps and hiring local student fixers to help navigate daily hospital bureaucracy.

Los mejores médicos del tratamiento de Adenocarcinoma en Xiamen - TOP-1 médicos

Recibe cotizaciones de 3 de los mejores especialistas en en China